Last reviewed · How we verify
Intranasal breast milk
At a glance
| Generic name | Intranasal breast milk |
|---|---|
| Sponsor | Semmelweis University |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Feasibility and Safety of Intranasally Administered Breast Milk in HIE (EARLY_PHASE1)
- Intranasal Breast Milk Therapy in HIE (EARLY_PHASE1)
- Effect of Intranasal Breast Milk Administration in Preterm Infants (NA)
- A Study to Learn How the Study Medicine Called Zavegepant is Taken Up Into Blood and Breast Milk of Healthy Breast-Feeding Women (PHASE1)
- Improved Diagnostics in Food Allergy Study (NA)
- Impact of Oxytocin on Obstructive Sleep Apnea Induced Changes in Sleep (PHASE2)
- Intranasal Human Milk for Intraventricular Hemorrhage (NA)
- Cerebrospinal Fluid Proteom in Dependence of Intranasal Breast Milk
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Intranasal breast milk CI brief — competitive landscape report
- Intranasal breast milk updates RSS · CI watch RSS
- Semmelweis University portfolio CI